BUY Supriya Lifescience Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1–3 months)2 Jul 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·24 Jun · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Supriya Lifescience
- BUY — Kush Bohra29 Sept 2026 · ~2 weeks · target ₹1,020 · SL hit
- BUY — Madhu Bansal29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY — Om Mehra, SAMCO Securities28 Sept 2026 · ~2 weeks · target ₹1,060 · SL hit
- BUY — Dharmesh Shah, ICICI Securities24 Sept 2026 · ~2 weeks · target ₹1,011 · Target hit
- BUY — Om Mehra, SAMCO Securities21 Sept 2026 · ~2 weeks · target ₹980 · Target hit
More from IDBI Capital
- BUY Bata India22 Oct 2026 · ~2 weeks · target ₹680 · Active
- BUY Tanla Platforms22 Oct 2026 · ~3 months · target ₹640 · Active
- BUY L&T Technology Services21 Oct 2026 · ~2 weeks · target ₹4,170 · Active
- BUY Fractal Analytics21 Oct 2026 · ~3 months · target ₹823 · Target hit
- BUY Meesho19 Oct 2026 · ~2 weeks · target ₹244.8 · SL hit

